183 related articles for article (PubMed ID: 34217244)
1. Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis.
Shang W; Yan C; Liu R; Chen L; Cheng D; Hao L; Yuan W; Chen J; Yang H
BMC Cancer; 2021 Jul; 21(1):770. PubMed ID: 34217244
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis.
Fang T; Liang T; Wang Y; Wu H; Liu S; Xie L; Liang J; Wang C; Tan Y
BMC Gastroenterol; 2021 Jul; 21(1):297. PubMed ID: 34301194
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis.
Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L
Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589
[TBL] [Abstract][Full Text] [Related]
4. FBXW7 mutation analysis and its correlation with clinicopathological features and prognosis in colorectal cancer patients.
Chang CC; Lin HH; Lin JK; Lin CC; Lan YT; Wang HS; Yang SH; Chen WS; Lin TC; Jiang JK; Chang SC
Int J Biol Markers; 2015 Feb; 30(1):e88-95. PubMed ID: 25450649
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic characteristics of FBXW7-mutated colorectal adenocarcinoma and association with aberrant beta-catenin localization.
Escobar D; Bushara O; Sun L; Liao J; Yang GY
Hum Pathol; 2022 Jan; 119():51-58. PubMed ID: 34717891
[TBL] [Abstract][Full Text] [Related]
6. FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma.
Korphaisarn K; Morris VK; Overman MJ; Fogelman DR; Kee BK; Raghav KPS; Manuel S; Shureiqi I; Wolff RA; Eng C; Menter D; Hamilton SR; Kopetz S; Dasari A
Oncotarget; 2017 Jun; 8(24):39268-39279. PubMed ID: 28424412
[TBL] [Abstract][Full Text] [Related]
7. Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases.
Kawaguchi Y; Newhook TE; Tran Cao HS; Tzeng CD; Chun YS; Aloia TA; Dasari A; Kopetz S; Vauthey JN
J Gastrointest Surg; 2021 Jan; 25(1):186-194. PubMed ID: 33205306
[TBL] [Abstract][Full Text] [Related]
8. Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance.
Iwatsuki M; Mimori K; Ishii H; Yokobori T; Takatsuno Y; Sato T; Toh H; Onoyama I; Nakayama KI; Baba H; Mori M
Int J Cancer; 2010 Apr; 126(8):1828-1837. PubMed ID: 19739118
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis.
Liu Y; Tang W; Wang J; Xie L; Li T; He Y; Qin X; Li S
Diagn Pathol; 2013 Nov; 8():181. PubMed ID: 24188373
[TBL] [Abstract][Full Text] [Related]
10. Pseudophosphatase STYX promotes tumor growth and metastasis by inhibiting FBXW7 function in colorectal cancer.
He D; Ma Z; Fang C; Ding J; Yang W; Chen P; Huang L; Wang C; Yu Y; Yang L; Li Y; Zhou Z
Cancer Lett; 2019 Jul; 454():53-65. PubMed ID: 30981757
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.
Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L
Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and Clinicopathological Significance of MUC Family Members in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Li C; Zuo D; Liu T; Yin L; Li C; Wang L
Gastroenterol Res Pract; 2019; 2019():2391670. PubMed ID: 31933627
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.
Zhang Y; Yang X
Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis.
Hu L; Huang M; Yuan Q; Kong F
Medicine (Baltimore); 2021 Apr; 100(15):e25441. PubMed ID: 33847647
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of MUC2 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Li C; Zuo D; Yin L; Lin Y; Li C; Liu T; Wang L
Gastroenterol Res Pract; 2018; 2018():6986870. PubMed ID: 29967641
[TBL] [Abstract][Full Text] [Related]
16. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
17. Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis.
Wang B; Li F; Zhou X; Ma Y; Fu W
World J Surg Oncol; 2019 Oct; 17(1):169. PubMed ID: 31639018
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathological significance of long non-coding RNA UCA1 in colorectal cancer: Results from a meta-analysis.
Liu X; Liu X; Qiao T; Chen W
Medicine (Baltimore); 2019 Nov; 98(48):e18031. PubMed ID: 31770217
[TBL] [Abstract][Full Text] [Related]
19. MiR-223 promotes the doxorubicin resistance of colorectal cancer cells via regulating epithelial-mesenchymal transition by targeting FBXW7.
Ding J; Zhao Z; Song J; Luo B; Huang L
Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):597-604. PubMed ID: 29701752
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic and prognostic implications of Golgi Phosphoprotein 3 in colorectal cancer: A meta-analysis.
Wang T; Fei J; Nie S
PLoS One; 2021; 16(11):e0260035. PubMed ID: 34807928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
